Aug. 14, 2024
Platform’s Matrix Pro® RF Microneedling Applicator Now Includes Expanded Indication for Facial Wrinkle Reduction
MARLBOROUGH, Massachusetts, August 14, 2024 – Candela Corporation (Candela), a leading global medical aesthetic device company headquartered in Marlborough, MA, today announced that the Matrix …
Read More
June 27, 2023
Marlborough, MASSACHUSETTS /June 28th, 2023 -- Candela Corporation (Candela), a leading global medical aesthetic device company headquartered in Marlborough, MA, today announced that the Vbeam Family of Pulsed Dye Lasers (PDL) has expanded its FDA cleared indications for use of …
Read More
March 8, 2023
Marlborough, MASSACHUSETTS /March 8, 2023/PRNEWSWIRE -- Candela Corporation (Candela), a leading global medical aesthetic device company headquartered in Marlborough, MA, today announced that the PicoWay® laser system has received FDA clearance and Health Canada licensing for expanded indications, including …
Read More
Feb. 6, 2023
Correct, Maintain and Restore Skin with the Profound Matrix™ System. Radiofrequency. Intelligently Redefined.
Marlborough, Massachusetts, February 6, 2023 – Candela, the leading provider of energy-based solutions worldwide, and the pioneer of the first and only long-pulse radiofrequency (RF) microneedling …
Read More
Jan. 14, 2021
Merz Aesthetics and Candela Corporation launch commercial collaboration creating broad medical aesthetics portfolio.
Committed to innovative customer solutions and meeting patient demand for full-spectrum of medical aesthetic treatment.
RALEIGH, N.C. – January 14, 2021 – In a unique commercial collaboration, …
Read More
June 17, 2020
The CO2RE laser platform offers women a nonsurgical, hormone-free treatment for genitourinary syndrome of menopause and stress urinary incontinence
MARLBOROUGH, MASSACHUSETTS, JUNE 17, 2020 – Candela Corporation, a leading global aesthetic device company, today announced that Health Canada …
Read More
Jan. 31, 2020
Candela to become the exclusive global commercial partner for the Exceed™ medical microneedling system of MT.DERM
MARLBOROUGH, Mass. and BERLIN, Jan. 31, 2020 /PRNewswire/ -- Candela Corporation, a leading global medical aesthetic device company, has entered into an exclusive collaboration …
Read More
July 16, 2019
Wayland, Mass. and Yokneam, Israel, July 16, 2019 -- Candela Corporation, a leading global aesthetic device company and the exclusive licensee of certain patents of General Hospital Corporation, d/b/a Massachusetts General Hospital, Lumenis Ltd., a global leader in the field …
Read More
May 5, 2019
30 pre-qualified patients will receive treatment with the Vbeam Pulsed Dye Laser to commence the E.V.A. clinic’s-Vascular Birthmarks Foundation’s International Congress on Vascular Anomalies in Athens, Greece, June 7-8, 2019.
For the second year the Vascular Birthmark Foundation (VBF) organizes …
Read More
March 20, 2019
WAYLAND, Mass. and LAKE FOREST, Calif., March 20, 2019 /PRNewswire/ -- Syneron Medical Ltd. and Candela Corporation (collectively, "Candela"), a leading global aesthetic device company and the exclusive licensee of certain patents of General Hospital Corporation, d/b/a Massachusetts General Hospital …
Read More
March 14, 2019
JAMA-Dermatology publishes Dr. Roy Geronemus' authored largest study of infants and babies receiving a non-invasive treatment (vs. surgery) for birthmarks, port wine stains and other vascular related skin conditions on the face and body using the Vbeam laser system.
WAYLAND, …
Read More
Nov. 12, 2018
WAYLAND, MASSACHUSETTS, NOVEMBER 12, 2018 – Candela Corporation, a leading global aesthetic device company, announces that the Profound® treatment has been named “New Treatment of the Year” by The Global Aesthetic Awards, a leading aesthetic industry award, also known …
Read More
Oct. 1, 2018
Syneron Candela Korea Co. Ltd focused on enhancing Customer Service in Growth Markets
WAYLAND, MASSACHUSETTS, October 1, 2018 - Syneron Candela announces the opening of Syneron Candela Korea Co Ltd, a new headquarters designed to support all commercial activities for …
Read More
Sept. 28, 2018
Over 30 pre-qualified patients will receive treatment with the Vbeam Pulsed Dye Laser to commence the Vascular Birthmarks Foundation's 18th Annual Conference.
WAYLAND, Mass., Sept. 26, 2018 /PRNewswire/ -- Candela Corporation, a leading global manufacturer of energy-based devices, announces it …
Read More
Sept. 5, 2018
Acquisition of Danish Ellipse adds globally renowned IPL and laser technologies to Candela’s portfolio, further strengthening their position in multi-application, multi-technology devices
WAYLAND, MASSACHUSETTS, September 5, 2018 – Candela Corporation, a leading global aesthetic device company, announces the acquisition of …
Read More
July 17, 2018
The new Vbeam Prima takes Candela’s “gold standard” 595 nm Pulsed Dye Laser (PDL) platform to the next level.
WAYLAND, MASSACHUSETTS, JULY 17, 2018 – Candela Corporation, a leading global aesthetic device company, announces the U.S. Food and Drug Administration …
Read More
Japan
Korea